Research Grade Anti-LILRB1 & LILRB2 Bispecific Antibody (Ngm707)Anti-LILRB1 & LILRB2 Bispecific Antibody (Ngm707) ( HV631036 ) is a research-grade recombinant antibody targeting CD85 . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns. Спецификация| Species reactivity | Human | | Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo | | Form | Liquid | | Storage | -20℃ | | Product category | Bispecific Antibodies | | Target | Leukocyte immunoglobulin-like receptor subfamily B member 1, LIR-1, Leukocyte immunoglobulin-like receptor 1, CD85 antigen-like family member J, Immunoglobulin-like transcript 2, ILT-2, Monocyte/macrophage immunoglobulin-like receptor 7, MIR-7, CD85j, LILRB1, Leukocyte immunoglobulin-like receptor subfamily B member 2, LIR-2, Leukocyte immunoglobulin-like receptor 2, CD85 antigen-like family member D, Immunoglobulin-like transcript 4, ILT-4, Monocyte/macrophage immunoglobulin-like receptor 10, MIR-10, CD85d, LILRB2 | | Accession | Q8NHL6 & Q8N423 | | Host species | Human | | | |
Информация для заказа| Область использования: | Производство: | Puda Scientific | | Метод: | Иммуногистохимия | | Объем: | 1mg | | Кат. номер: | PD-A26-15522-100 | | Цена (с НДС 22%): | по запросу | В корзину  | Наименование: Research Grade Anti-LILRB1 & LILRB2 Bispecific Antibody (Ngm707).
Примечание: |
|
